registered   |   log in
  中文

Academic Frontier

 
contact us

hotline:

17715390137

Tel/Wechat:

  18101240246 (Technology)

0512-68565571

Emailmxenes@163.com (Sales Engineer)bkxc.bonnie@gmail.com

Scan the code to follow or search the official account on WeChat: 

2D Materials Fronrier After paying attention, 

click on the lower right corner to contact us, 

Enter enterprise WeChat.

Professional Services Online

Academic Frontier
position: home > Academic Frontier > Nanozyme

ACS Nano | Bionically Selenium-Coated Prussian Blue Nanozyme Enhances Mitophagy and Reactive Oxygen Species Clearance Through Coordination to Treat Myocardial Infarction

source:material synthesis Views:24time:2026-02-25material synthesis: 1092348845

已传文件:photo/1771980306.png

The vicious cycle between reactive oxygen species (ROS) rupture and mitochondrial damage is a central pathological driver of myocardial infarction (MI). Effectively promoting ROS clearance while enhancing mitochondrial phagocytosis to achieve dual restoration of redox homeostasis and energy metabolism is key to treating myocardial infarction. To this end, we have developed a bioinspired sesame-like cube doped with selenium Prussian blue nanozymes (SP), with active sites of Se0/Fe2/Fe3. By utilizing the superoxide dismutase (SOD)-like activity of the nanozymes, superoxide anions (·O2–) are converted into hydrogen peroxide (H2O2). Simultaneously, the catalase (CAT)-mimicking activity of the material further breaks down H2O2 to produce oxygen (O2), while selenium-enhanced electron transfer synergistically activates PINK1/Parkin-mediated mitochondrial clearance.

Subsequently, the nanozyme was integrated into a hydrogel, forming SP@Gel through dynamic Schiff base crosslinking between aldehyde-modified hyaluronic acid and amine-functionalized nanozymes. After being injected into the blocked myocardium, this hydrogel can continuously release the nanozyme. The SP@Gel exhibits excellent capability in promoting ROS clearance and alleviating oxidative damage, thereby improving myocardial redox homeostasis. Additionally, SP@Gel enhances cardiac mitophagy flux and regulates this process via the PTEN-induced kinase 1 (PINK1)/Parkin/microtubule-associated protein 1 light chain 3β (LC3B) pathway, promoting the restoration of mitochondrial structure and energy metabolism. These findings were further validated through metabolomics analysis. SP@Gel injection mediates remodeling of the myocardial infarction microenvironment, significantly reducing infarct size, inhibiting fibrosis, promoting angiogenesis, and notably improving cardiac function. This integrated nanozyme-hydrogel system represents a promising therapeutic strategy for myocardial infarction, achieving synergistic treatment through dual regulation of oxidative stress and mitochondrial quality control.



 

Reminder: Beijing Beike New Material Technology Co., Ltd. supplies products only for scientific research, not for humans
All rights reserved © 2019 beijing beike new material Technology Co., Ltd 京ICP备16054715-2号
advisory
phone
Email:mxenes@163.com
Tel:+86-17715390137
scan

scan
WeChat